The INTER-ROMA Project - A survey among Italian radiation oncologists on their approach to the treatment of bone metastases

Tumori

Volumn 97, Issue 2, 2011, Pages 177-184

  De Bari, Berardino ^a   Chiesa, Silvia ^b   Filippi, Andrea Riccardo ^c   Gambacorta, Maria Antonietta ^b   D'Emilio, Valentina ^d   Murino, Paola ^e   Livi, Lorenzo ^f  

^a UNIVERSITÉ LYON 1   (France)

^b CATHOLIC UNIVERSITY   (Italy)

^c UNIVERSITY OF TURIN   (Italy)

^d CIVILE M P AREZZO HOSPITAL   (Italy)

^e CARDARELLI HOSPITAL   (Italy)

^f UNIVERSITY OF FLORENCE   (Italy)

Author keywords

Bone metastases; INTER ROMA; Palliative radiotherapy; Patterns of care; Survey

Indexed keywords

FENTANYL; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE;

ADULT; AGED; ARTICLE; BONE METASTASIS; CANCER LOCALIZATION; CANCER PAIN; CANCER PALLIATIVE THERAPY; CANCER RADIOTHERAPY; CASE REPORT; CLINICAL DECISION MAKING; CONTROLLED STUDY; EVIDENCE BASED MEDICINE; FEMALE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; ITALY; LOW BACK PAIN; MALE; PAIN ASSESSMENT; PHYSICIAN ATTITUDE; PRIMARY TUMOR; QUALITY OF LIFE; RADIATION DOSE; SPINE METASTASIS; TREATMENT INDICATION; TREATMENT PLANNING;

EID: 79957659499     PISSN: 03008916     EISSN: 20382529     Source Type: Journal    
DOI: 10.1177/030089161109700208     Document Type: Article

References (55)

1. Coleman RE, Rubens RD: The clinical course of bone metastases from breast cancer. Br J Cancer, 55: 61-66, 1987. (Pubitemid 17234155)
2. Hoskin PJ: Radiotherapy in the management of bone pain. Clin Orthop, 312: 105-119, 1995.
3. Falkmer U, Jarhult J, Wersall P, Cavallin-Stahl E: A systematic overview of radiation therapy effects in skeletal metastases. Acta Oncol, 42: 620-633, 2003. (Pubitemid 37193849)
4. Rose CM, Kagan R: The final report of the expert panel for the radiation oncology bone metastasis work group of the American College of Radiology. Int J Radiat Oncol Biol Phys, 40: 1117-1124, 1998. (Pubitemid 28152927)
5. Tong D, Gillick L, Hendrickson FR: The palliation of symptomatic osseous metastases. final results of the study by the Radiation Therapy Oncology Group. Cancer, 50: 893-899, 1982. (Pubitemid 12047122)
6. Hartsell WF, Scott CB, Bruner DW, Scarantino CW, Ivker RA, Roach M 3rd, Suh JH, Demas WF, Movsas B, Petersen IA, Konski AA, Cleeland CS, Janjan NA, DeSilvio M: Randomized trial of short- versus long-course radiotherapy for palliation of painful bone metastases. J Natl Cancer Inst, 97: 798-804, 2005. (Pubitemid 40909122)
7. Steenland E, Leer JW, van Houwelingen H, Post WJ, van den Hout WB, Kievit J, de Haes H, Martijn H, Oei B, Vonk E, van der Steen-Banasik E, Wiggenraad RG, Hoogenhout J, Wárlám-Rodenhuis C, van Tienhoven G, Wanders R, Pomp J, van Reijn M, van Mierlo I, Rutten E: The effect of a single fraction compared to multiple fractions on painful bone metastases: a global analysis of the Dutch Bone Metastasis Study. Radiother Oncol, 52: 101-109, 1999. (Pubitemid 29461077)
8. Madsen EL: Painful bone metastasis: Efficacy of radiotherapy assessed by the patients - A randomized trial comparing 4 Gy x 6 versus 10 Gy x 2. Int J Radiat Oncol Biol Phys, 9: 1775-1779, 1983.
9. Niewald M, Tkocz HJ, Abel U, Scheib T, Walter K, Nieder C, Schnabel K, Berberich W, Kubale R, Fuchs M: Rapid course radiation therapy vs. more standard treatment: A randomized trial for bone metastases. Int J Radiat Oncol Biol Phys, 36: 1085-1089, 1996. (Pubitemid 27014494)
10. Shakespeare TP, Thiagarajan A, Gebski V: Evaluation of the quality of radiotherapy randomized trials for painful bone metastases. Cancer, 103: 1976-1981, 2005.
11. Jeremic B, Shibamoto Y, Acimovic L, Milicic B, Milisavljevic S, Nikolic N, Aleksandrovic J, Igrutinovic I: A randomized trial of three single-dose radiation therapy regimens in the treatment of metastatic bone pain. Int J Radiat Oncol Biol Phys, 42: 161-167, 1998. (Pubitemid 28435609)
12. Bone Pain Trial Working Group: 8 Gy single fraction radiotherapy for the treatment of metastatic skeletal pain: Randomised comparison with a multifraction schedule over 12 months of patient follow-up. Radiother Oncol, 52: 111-121, 1999.
13. Blitzer PH: Reanalysis of the RTOG study of the palliation of symptomatic osseous metastasis. Cancer, 55: 1468-1472, 1984.
14. Price P, Hoskin PJ, Easton D, Austin D, Palmer SG, Yarnold JR: Prospective randomized trial of single and multifraction radiotherapy schedules in the treatment of painful bony metastases. Radiother Oncol, 6: 247-255, 1986. (Pubitemid 16026730)
15. Wu JS, Wong R, Johnston M, Bezjak A, Whelan T; Cancer Care Ontario Practice Guidelines Initiative Supportive Care Group: Meta-analysis of dose fractionation radiotherapy trials for the palliation of painful bonemetastases. Int J Radiat Oncol Biol Phys, 55: 594-605, 2003.
16. Sze WM, Shelley M, Held I, Mason M: Palliation of metastatic bone pain: single fraction versus multifraction radiotherapy - a systematic review of the randomised trials. Cochrane Database Syst Rev, 2: CD004721, 2004.
17. Roos DE: Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: An Australian and New Zealand practice survey and literature review. Radiother Oncol, 56: 315-322, 2000.
18. Chander SS, Sarin R: Single fraction radiotherapy for bone metastases: Are all questions answered? Radiother Oncol, 52: 191-193, 1999.
19. Crellin AM, Marks A, Maher EJ: Why don't British radiotherapists give single fractions of radiotherapy for bone metastases? Clin Oncol (R Coll Radiol), 1: 63-66, 1989.
20. Fairchild A, Barnes E, Ghosh S, Ben-Josef E, Roos D, Hartsell W, Holt T, Wu J, Janjan N, Chow E: International patterns of practice in palliative radiotherapy for painful bone metastases: evidence-based practice? Int J Radiat Oncol Biol Phys, 75: 1501-1510, 2009.
21. Lievens Y, Van den Bogaert W, Rijnders A, Kutcher G, Kesteloot K: Palliative radiotherapy practice within Western European countries: impact of the radiotherapy financing system? Radiother Oncol, 56: 289-295, 2000.
22. Maher E, Coia L, Duncan G, Lawton PA: Treatment strategies in advanced andmetastatic cancer: differences in attitude between the USA, Canada and Europe. Int J Radiat Oncol Biol Phys, 23: 239-244, 1992.
23. van den Hout W, van der Linden Y, Steenland E, Wiggenraad RG, Kievit J, de Haes H, Leer JW: Single versus multiple-fraction radiotherapy in patients with painful bone metastases: cost-utility analysis based on a randomized trial. J Natl Cancer Inst, 5; 95: 222-229, 2003. (Pubitemid 36240635)
24. Pollicino C, Turner S, Roos D, O'Brien PC: Costing the components of pain management: analysis of Trans-Tasman Radiation Oncology Group trial (TROG 96.05): one versus five fractions for neuropathic bone pain. Radiother Oncol, 76: 264-269, 2005. (Pubitemid 41394276)
25. Konski A: Radiotherapy is a cost-effective palliative treatment for patients with bonemetastases fromprostate cancer. Int J Radiat Oncol Biol Phys, 60: 1373-1378, 2004.
26. Szumacher E, Llewellyn-Thomas H, Franssen E, Chow E, DeBoer G, Danjoux C, Hayter C, Barnes E, Andersson L: Treatment of bonemetastases with palliative radiotherapy: patients' treatment preferences. Int J Radiat Oncol Biol Phys, 61: 1473-1481, 2004.
27. Shakespeare T, Lu J, Back M, Liang S, Mukherjee RK, Wynne CJ: Patient preference for radiotherapy fractionation schedule in the palliation of painful bone metastases. J Clin Oncol, 21: 2156-2162, 2003. (Pubitemid 46606364)
28. Chow E, Danjoux C, Wong R, Szumacher E, Franssen E, Fung K, Finkelstein J, Andersson L, Connolly R: Palliation of bone metastases: a survey of patterns of practice among Canadian radiation oncologists. Radiother Oncol, 56: 305-314, 2000.
29. van der Linde Y, Roos D, Lutz S, Fairchild A: International variations in radiotherapy fractionation for bone metastases: geographic borders define practice patterns? Clin Oncol, 21: 655-658, 2009.
30. Pergolizzi S, Pontoriero A, Delia P, Santacaterina A: External beam irradiation in the palliation of bone metastases: a practice analysis among Sicilian departments of radiation oncology. Tumori, 90: 86-90, 2004. (Pubitemid 38541733)
31. Bradley NM, Husted J, Sey MS, Husain AF, Sinclair E, Harris K, Chow E: Review of patterns of practice and patients' preferences in the treatment of bone metastases with palliative radiotherapy. Support Care Cancer, 15: 373-385, 2006.
32. Roos DE: Continuing reluctance to use single fractions of radiotherapy for metastatic bone pain: an Australian and New Zealand practice survey and literature review. Radiother Oncol, 56: 315-322, 2000.
33. Coia LR, Owen JB, Maher EJ, Hanks GE: Factors affecting treatment patterns of radiation oncologists in the United States in the palliative treatment of cancer. Clin Oncol (R Coll Radiol), 4: 6-10, 1992.
34. Mercadante S, Fulvaro F: World Health Organisation guidelines for cancer pain: a reappraisal. Ann Oncol, 16 (suppl 4): 132-135, 2005.
35. http://www.cancer.gov/cancertopics/pdq/supportivecare/pain/Patient/page4.
36. NCCN: Clinical practice guidelines in Oncology. Adult cancer pain. Available at http://www.nccn.org/professionals/physician-gls/PDF/pain.pdf (accessed March 29, 2011).
37. Hartsell WF, Konski AA, Lo SS, Hayman JA: Single fraction radiotherapy for bone metastases: clinically effective, time efficient, cost conscious and still underutilized in the United States? Clin Oncol (Coll Radiol), 21: 652-654, 2009.
38. Pradier O, Bouchekoua M, Albargach N, Muller M, Malhaire JP: How to irradiate bone metastases? Cancer Radiother, 12: 837-841, 2008.
39. Brady LW, Perez CA, Halperin EC (Eds): Principles and practice of radiation oncology, 5th edition. Lippincott Williams & Wilkins, Philadelphia, 2007.
40. Andic F, Baz Cifci S, Ors Y, Niang U, Dirier A, Adli M: A dosimetric comparison of different treatment plans of palliative spinal bone irradiation: analysis of dose coverage with respect to ICRU 50 Report. J Exp Clin Cancer Res, 28: 2, 2009.
41. Rezvoy N, Dubray B: Probabilities of organs at risk damage: history and mathematical models. Cancer Radiother, 14: 241-245, 2010.
42. Pointreau Y, Kreps S, Hennequin C: Side effects evaluation of ionizing radiation. Cancer Radiother, 14: 246-249, 2010.
43. Azria D, Pointreau Y, Toledano A, Ozsahin M: Factors of late radiosensitivity of normal tissues. Cancer Radiother, 14: 250-254, 2010.
44. Martin E, Pointreau Y, Roche-Forestier S, Barillot I: Normal tissue tolerance to external beam radiation therapy: small bowel. Cancer Radiother, 14: 350-353, 2010.
45. De Bari B, Pointreau Y, Rio E, Mirabel X, Mornex F: Normal tissue tolerance to external beam radiation therapy: liver. Cancer Radiother, 14: 344-349, 2010.
46. Oberdiac P, Mineur L: Normal tissue tolerance to external beam radiation therapy: the stomach. Cancer Radiother, 14: 336-339, 2010.
47. Bera G, Pointreau Y, Denis F, Orain I, Dupuis O, Créhange G: Normal tissue tolerance to external beam radiation therapy: esophagus. Cancer Radiother, 14: 327-335, 2010.
48. Doyen J, Giraud P, Belkacemi Y: Normal tissue tolerance to external beam radiation therapy: cardiac structures. Cancer Radiother, 14: 319-326, 2010.
49. Ortholan C, Mornex F: Normal tissue tolerance to external beam radiation therapy: lung. Cancer Radiother, 14: 312-318, 2010.
50. Blanchard P, Chapet O: Normal tissue tolerance to external beam radiation therapy: rectum. Cancer Radiother, 14: 354-358, 2010.
51. Pointreau Y, Atean I, Durdux C: Normal tissue tolerance to external beam radiation therapy: bladder. Cancer Radiother, 14: 363-368, 2010.
52. Barton R, Robinson G, Gutierrez E, Kirkbride P, McLean M: Palliative radiation for vertebral metastases: the effect of variation in prescription parameters on the dose received at depth. Int J Radiat Oncol Biol Phys, 52: 1083-1091, 2002. (Pubitemid 34219030)
53. Maranzano E, Feyer PC, Molassiotis A, Rossia R, Clark-Snow RA, Olver I, Warr D, Schiavone C, Roila F, on behalf of Participants in the Perugia Consensus Conference 2004: Evidence-based recommendations for the use of antiemetics in radiotherapy. Radiother Oncol, 76: 227-233, 2005.
54. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, Elting LS, Fox PC, Cooksley C, Sonis ST; Mucositis Study Section of the Multinational Association for Supportive Care in Cancer; International Society for Oral Oncology: Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer, 100 (9 Suppl): 2026-2046, 2004.
55. Steer CB, Harper PG: Gastro-oesophageal complications in patients receiving cancer therapy: the role of proton pump inhibitors. Eur J Gastroenterol Hepatol, 14 (Suppl 1): S17-21, 2002.